Tag: Vaccines
Vaccination, NPI Compliance Needed to Prevent COVID-19 Surges
Accelerated decline in nonpharmaceutical intervention adherence could undermine vaccine-related gains
Two Doses of BNT162b2 SARS-CoV-2 Vaccine Highly Effective
Real-world study shows vaccine effectiveness of 97.2 percent against COVID-19-related hospitalization, 96.7 percent against COVID-19-related death
Pfizer to Seek Approval in Fall for COVID-19 Vaccine Use in Children Aged 2...
Company also plans to apply to the FDA this month for full approval of the vaccine for use in people ages 16 to 85 years
Biden Administration to Back Lifting of COVID-19 Vaccine Patents
Global health activists note that patent holders must also share technical know-how and personnel
HPV Vaccination Rates Low for Young Adults
Rates low for 18- to 21-year-olds reporting vaccination at any age or initiating in young adulthood
COVID-19 Vaccine Hesitancy Found for 20 Percent on Hemodialysis
Increased odds of vaccine hesitancy seen for patients aged 18 to 44 years, Black and Native Americans or Pacific Islanders, women
Biden Sets New Goal of Vaccinating 70 Percent of Americans by July 4
So far, more than 56 percent of American adults have received at least one dose of a COVID-19 vaccine; more than 106 million fully vaccinated
Canada Approves Pfizer COVID-19 Vaccine for Children Ages 12 to 15
Chief medical adviser at Health Canada says evidence is that the vaccine is safe and effective in the younger age group
12 Cases of CVST Reported for Ad26.COV2.S Vaccine in the U.S.
Time from vaccination to symptom onset varied from six to 15 days; initial presentation was headache in 11 cases
HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years
For most of the study period, higher rates of HPV vaccination initiation and up-to-date rates were seen for non-Hispanic Blacks, Hispanics












